Effectiveness of Eribulin in Metastatic Breast Cancer: 10 Years of Real-World Clinical Experience in the United States.

Sarah S MougalianJonathan K KishJingchuan ZhangDjibril LiassouBruce A Feinberg

Published in: Advances in therapy (2021)

The current retrospective chart review study reinforces the clinical effectiveness of eribulin in patients with MBC, including those with TNBC, when used according to the approved US indication in real-world clinical practice.

Keyphrases

metastatic breast cancer
clinical practice
randomized controlled trial
systematic review
clinical trial
phase ii
study protocol
open label